Skip to main content
Livermore
Livermore
ZHEN

Profund Advisors LLC

SEC CIK
0001129919
Latest filing
Aug 11, 2026

PCRX holding history

Pacira BioSciences, Inc. in every 13F filed by Profund Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PCRX overviewAll 13F holders of PCRXFull Q2 2026 holdings

Shares (Q2 2026)
13,035
Value
$330.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of PCRX by Profund Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202613,035$330.7K<0.1%+1,143+9.6%AddedHolders
Q1 202611,892$268.8K<0.1%+19+0.2%AddedHolders
Q4 202511,873$307.3K<0.1%+1,347+12.8%AddedHolders
Q3 202510,526$271.3K<0.1%−1,718−14.0%ReducedHolders
Q2 202512,244$292.6K<0.1%−1,621−11.7%ReducedHolders
Q1 202513,865$344.5K<0.1%+2,139+18.2%AddedHolders
Q4 202411,726$220.9K<0.1%−5,985−33.8%ReducedHolders
Q3 202417,711$266.6K<0.1%+7,160+67.9%AddedHolders
Q2 202410,551$301.9K<0.1%+2,190+26.2%AddedHolders
Q1 20248,361$244.3K<0.1%−2,645−24.0%ReducedHolders
Q4 202311,006$371.3K<0.1%−1,252−10.2%ReducedHolders
Q3 202312,258$376.1K<0.1%+2,415+24.5%AddedHolders
Q2 20239,843$394.4K<0.1%−524−5.1%ReducedHolders
Q1 202310,367$423.1K<0.1%+4,363+72.7%AddedHolders
Q4 20226,004$231.8K<0.1%−296−4.7%ReducedHolders
Q3 20226,300$335.0K<0.1%−347−5.2%ReducedHolders
Q2 20226,647$388.0K<0.1%−717−9.7%ReducedHolders
Q1 20227,364$562.0K<0.1%+140+1.9%AddedHolders
Q4 20217,224$435.0K<0.1%+128+1.8%AddedHolders
Q3 20217,096$397.0K<0.1%−922−11.5%ReducedHolders
Q2 20218,018$487.0K<0.1%+548+7.3%AddedHolders
Q1 20217,470$524.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.